RDPAC药品推广行为准则 - IFPMA

研
制
开
发
制
药
企
业
协
会
款清晰界定了推广行为的是非标
准。我们的会员公司也纷纷以积极
响应新准则的宗旨和原则的方式践
行了研发制药行业在中国医改事业
中所应承担的责任。
我在此号召RDPAC每家会员
公司都把我们的上述承诺不间断地
传递到公司组织机构的每个单元;
同时,作为行业的每个成员以及全
行业都应在我们与医疗卫生专业人
士的互动活动中对准则的严格执行
负责。只有通过这样的实际行动,
我们才能展现我行业努力以最高道
德标准服务于中国医疗卫生事业的
决心和愿望。
2
as articulated in twelve Articles of
the RDPAC Code of Practice. Our
Member Companies have fully endorsed
both the spirit and the letter
of the Code in respect of our role in
healthcare in China.
I call upon each Member Company
to consistently convey this commitment
throughout their organization
and to hold ourselves individually
and collectively accountable for the
full implementation of the Code in
all our professional interactions with
healthcare professions. Through
this endeavor we will demonstrate
our close alignment with the medical
needs of the Chinese patients
and the highest principles of ethical
medical practice.
庄祥兴 主席
Chong Siong Hin
Chairman, RDPAC